A Phase II Clinical Trial of Ixabepilone (Ixempra; BMS-247550; NSC 710428), an Epothilone B Analog, in Patients With Metastatic Renal Cell Carcinoma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-0379
Full Text
Open PDFAbstract
Available in full text
Date
February 23, 2010
Authors
Publisher
American Association for Cancer Research (AACR)